New supplementary intraocular lens for refractive enhancement in pseudophakic patients.
To assess the efficacy and safety of implanting a secondary intraocular lens (IOL) in the ciliary sulcus to correct pseudophakic ametropia. Department of Ophthalmology, Medical University of Vienna, Vienna, Austria. This prospective nonrandomized study included patients who had implantation of a secondary IOL (Sulcoflex 653L) to correct residual refractive error after phacoemulsification with IOL implantation in the capsular bag. After implantation of the secondary IOL in the ciliary sulcus, visual and refractive outcomes were evaluated. Inflammation was measured with a laser flare-cell meter. The position and rotation of the IOLs were documented at all control visits, and Scheimpflug images were taken. Postoperative follow-up was at 1 week and 1, 6, 12, and 17 months. Twelve eyes of 10 patients were evaluated. The mean spherical equivalent decreased from -1.25 diopters (D) +/- 0.25 (SD) (range -2.00 to +4.00 D) preoperatively to -0.25 +/- 0.40 D (range -0.50 to +0.25 D) postoperatively. Uncorrected distance visual acuity improved in all cases. There were no significant intraoperative or postoperative complications. Sulcus implantation of the secondary IOL to correct pseudophakic refractive error was safe and predictable. The IOL was well tolerated in all eyes. Neither author has a financial or proprietary interest in any material or method mentioned. Additional disclosures are found in the footnotes.